November 2021 - Cancer Currents Blog
-
Shorter, More Intensive Radiation Safe after Surgery for Prostate CancerMany with prostate cancer can safely receive shorter, higher-dose radiation therapy after surgery, a new study has found. The approach, called HYPORT, didn’t harm patients’ quality of life compared with the standard radiation approach, trial finds.
-
Tecartus Becomes First CAR T-Cell Therapy Approved for Adults with ALLThe CAR T-cell therapy Tecartus has become the first such treatment approved by FDA to treat adults with acute lymphoblastic leukemia (ALL). The approval is for patients whose cancer has not responded to treatment or returned after treatment.
-
New on NCI’s Websites for November 2021NCI periodically provides updates on new websites and other online content of interest to the cancer community. See selected content that has been added as of November 2021.
-
Studies Delve Deep into the Protein Machinery of Cancer CellsA research team has identified common interactions between cancer-related proteins in cancer cells. They also created a map of how these protein complexes function in those cells and identified a promising treatment target for head and neck cancer.